Literature DB >> 6639290

Risk, protective factors, and supportive interventions in chronic airway obstruction.

P S Jensen.   

Abstract

Fifty-nine patients with chronic airway obstruction completed the Schedule of Recent Experiences and Social Assets Scale (SAS) to measure life stress and social supports. Patients with highest stress and lowest SAS scores (the high-risk group) were randomly assigned to a pulmonary rehabilitation group, self-help support group, or waiting-list control group. Patients with lower stress and/or higher SAS scores (the low-risk group) served as controls. Six months later, a records review showed that high-risk control patients were hospitalized more often than low-risk control patients and for more days than high-risk patients in rehabilitation and self-help support groups. Discriminant analysis determined that SAS and life stress scores predicted subsequent hospitalization, but age, sex, previous hospitalizations, and severity of illness did not. Measurements of stress and social supports can help identify high-risk patients. In turn, professionals might assist these patients by increasing their supports.

Entities:  

Mesh:

Year:  1983        PMID: 6639290     DOI: 10.1001/archpsyc.1983.01790100049007

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  3 in total

1.  Rehabilitation for people with chronic lung disease.

Authors:  M D Morgan; F H Quirk; S J Singh
Journal:  Qual Health Care       Date:  1995-12

2.  Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease.

Authors:  C A Ketelaars; M A Schlösser; R Mostert; H Huyer Abu-Saad; R J Halfens; E F Wouters
Journal:  Thorax       Date:  1996-01       Impact factor: 9.139

3.  Rehabilitation for patients with chronic obstructive pulmonary disease: meta-analysis of randomized controlled trials.

Authors:  Ghassan F Salman; Michael C Mosier; Brent W Beasley; David R Calkins
Journal:  J Gen Intern Med       Date:  2003-03       Impact factor: 5.128

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.